A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor

Characterization of the Neurochemical and Behavioral Effects of Solriamfetol (JZP-110), a Selective Dopamine and Norepinephrine Reuptake Inhibitor

(2018) Michelle G. Baladi et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

0644 A PHASE 3, PLACEBO-CONTROLLED, RANDOMIZED-WITHDRAWAL, DOUBLE-BLIND, 6-WEEK MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF JZP-110 FOR THE TREATMENT OF EXCESSIVE SLEEPINESS IN PARTICIPANTS WITH OBSTRUCTIVE SLEEP APNEA

(2017) PJ Strollo et al.   SLEEP

0644 A PHASE 3, PLACEBO-CONTROLLED, RANDOMIZED-WITHDRAWAL, DOUBLE-BLIND, 6-WEEK MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF JZP-110 FOR THE TREATMENT OF EXCESSIVE SLEEPINESS IN PARTICIPANTS WITH OBSTRUCTIVE SLEEP APNEA

(2017) PJ Strollo et al.   SLEEP

The Humanistic and Economic Burden of Narcolepsy

(2016) Natalia M. Flores et al.   Journal of Clinical Sleep Medicine

Effect of Oral JZP-110 (ADX-N05) on Wakefulness and Sleepiness in Adults with Narcolepsy: A Phase 2b Study

(2016) Chad Ruoff et al.   SLEEP

Risk of Occupational Accidents in Workers with Obstructive Sleep Apnea: Systematic Review and Meta-analysis

(2016) Sergio Garbarino et al.   SLEEP

Effect of Oral JZP-110 (ADX-N05) on Wakefulness and Sleepiness in Adults with Narcolepsy: A Phase 2b Study

(2016) Chad Ruoff et al.   SLEEP

Risk of Occupational Accidents in Workers with Obstructive Sleep Apnea: Systematic Review and Meta-analysis

(2016) Sergio Garbarino et al.   SLEEP

The Effect of OSA on Work Disability and Work-Related Injuries

(2015) A. J. Marcus Hirsch Allen et al.   CHEST

Recommended Treatment Strategies for Patients With Excessive Daytime Sleepiness

(2015) Russell P. Rosenberg   JOURNAL OF CLINICAL PSYCHIATRY

Clinical and practical considerations in the pharmacologic management of narcolepsy

(2015) Michael J. Thorpy et al.   SLEEP MEDICINE

Effect of oral JZP-110 (ADX-N05) treatment on wakefulness and sleepiness in adults with narcolepsy

(2015) Richard K. Bogan et al.   SLEEP MEDICINE

The Burden of Narcolepsy Disease (BOND) study: health-care utilization and cost findings

(2014) Jed Black et al.   SLEEP MEDICINE

2012 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 30th Annual Report

(2013) James B. Mowry et al.   CLINICAL TOXICOLOGY

Human Abuse Potential and Cognitive Effects of Taranabant, a Cannabinoid 1 Receptor Inverse Agonist

(2012) Kerri A. Schoedel et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Subjective and Objective Effects of the Novel Triple Reuptake Inhibitor Tesofensine in Recreational Stimulant Users

(2010) K A Schoedel et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Sleep disorders and accidental risk in a large group of regular registered highway drivers

(2010) Pierre Philip et al.   SLEEP MEDICINE

Principles of laboratory assessment of drug abuse liability and implications for clinical development

(2009) Lawrence P. Carter et al.   DRUG AND ALCOHOL DEPENDENCE

Abuse liability assessment of atomoxetine in a drug-abusing population

(2008) Donald R. Jasinski et al.   DRUG AND ALCOHOL DEPENDENCE